Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study
information for practice,
Mandatory trial registration, and later results reporting, were proposed to mitigate selective clinical trial publication and…